Literature DB >> 11872188

Do over-the-counter medications help the physician manage migraine headache?

Frederick G Freitag1.   

Abstract

The use of over-the-counter-medication in migraine treatment is commonplace. They are often used in addition to physician-prescribed medications and may be used without the full knowledge of the physician. Although considerable evidence suggests their efficacy in migraine treatment, they are rarely used to maximal levels of efficacy and safety. A review of the evidence for these treatments is important for cost effective, well-tolerated, and specific treatment of migraine headache.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872188     DOI: 10.1007/s11916-002-0013-x

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  33 in total

1.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

2.  Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study.

Authors:  V Pfaffenrath; P Wessely; C Meyer; H R Isler; S Evers; K H Grotemeyer; Z Taneri; D Soyka; H Göbel; M Fischer
Journal:  Cephalalgia       Date:  1996-10       Impact factor: 6.292

3.  Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study.

Authors:  D E Kellstein; R B Lipton; R Geetha; K Koronkiewicz; F T Evans; W F Stewart; K Wilkes; S A Furey; T Subramanian; S A Cooper
Journal:  Cephalalgia       Date:  2000-05       Impact factor: 6.292

4.  Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.

Authors:  J Schoenen; J Jacquy; M Lenaerts
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

5.  Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials.

Authors:  R B Lipton; W F Stewart; R E Ryan; J Saper; S Silberstein; F Sheftell
Journal:  Arch Neurol       Date:  1998-02

6.  Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine.

Authors:  J Goldstein; H D Hoffman; J J Armellino; J P Battikha; S W Hamelsky; J Couch; H Blumenthal; R B Lipton
Journal:  Cephalalgia       Date:  1999-09       Impact factor: 6.292

7.  Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study.

Authors:  M L Hämäläinen; K Hoppu; E Valkeila; P Santavuori
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

8.  Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study.

Authors:  P Tfelt-Hansen; J Olesen
Journal:  Cephalalgia       Date:  1984-06       Impact factor: 6.292

9.  Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study.

Authors:  A Peikert; C Wilimzig; R Köhne-Volland
Journal:  Cephalalgia       Date:  1996-06       Impact factor: 6.292

10.  Caffeine as an analgesic adjuvant in tension headache.

Authors:  J R Migliardi; J J Armellino; M Friedman; D B Gillings; W T Beaver
Journal:  Clin Pharmacol Ther       Date:  1994-11       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.